• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节病的病理生理学及对类固醇治疗的反应

The pathophysiology and response to steroid therapy in sarcoidosis.

作者信息

Ploysongsang Y, Roberts R D

出版信息

Respiration. 1986;49(3):204-15. doi: 10.1159/000194880.

DOI:10.1159/000194880
PMID:3961284
Abstract

Fourteen patients with early sarcoidosis were prospectively studied over a period of 12-24 months. After baseline physiologic measurements they were treated with 40 mg of prednisone daily for 8 weeks and the measurements were repeated. Thereafter, the steroid dosage was reduced to 0-10 mg every other day and the measurements were repeated between the 12th and 24th month. Relatively normal lung volumes (VC, FRC, RV, TLC) and low DLCO increased with 8-week intensive steroid treatment and fell to below the pretreatment levels when the steroid was either tapered or stopped. The Vmax50-air, Vmax50-He, FEF25-75, upstream conductance (Gus) increased during intensive treatment whereas the RL fell and the FEV1/FVC ratio did not change. The CC/TLC, CV/VC, delta N2, CLdyn/CLst, delta Vmax50 were abnormal in many patients and did not change after 8 weeks of steroid treatment. We concluded that the obstructive defect is common in early sarcoidosis, predominantly in small airways and patchy in nature; the functional derangement is always improved by intensive and adequate steroid therapy and worsened when the drug is tapered or stopped.

摘要

对14例早期结节病患者进行了为期12至24个月的前瞻性研究。在进行基线生理测量后,他们每天接受40毫克泼尼松治疗,持续8周,然后重复测量。此后,类固醇剂量减至每隔一天0至10毫克,并在第12个月至24个月期间重复测量。相对正常的肺容积(肺活量、功能残气量、残气量、肺总量)和低一氧化碳弥散量在8周的强化类固醇治疗后增加,而当类固醇减量或停药时则降至治疗前水平以下。在强化治疗期间,最大呼气中期流速-空气、最大呼气中期流速-氦气、用力呼气流量25%-75%、上游传导率增加,而比气道阻力下降,第一秒用力呼气容积/用力肺活量比值未改变。许多患者的闭合气量/肺总量、闭合容量/肺活量、氮浓度差、动态顺应性/静态顺应性、最大呼气中期流速变化异常,在类固醇治疗8周后没有改变。我们得出结论,阻塞性缺陷在早期结节病中很常见,主要发生在小气道,且呈斑片状;强化且适当的类固醇治疗总能改善功能紊乱,而当药物减量或停药时则会恶化。

相似文献

1
The pathophysiology and response to steroid therapy in sarcoidosis.结节病的病理生理学及对类固醇治疗的反应
Respiration. 1986;49(3):204-15. doi: 10.1159/000194880.
2
Functional evaluation in stage I pulmonary sarcoidosis.I期肺结节病的功能评估
Respiration. 1986;49(3):195-203. doi: 10.1159/000194879.
3
Daily vs alternate day prednisone therapy for stage II sarcoidosis.
Chest. 1985 Nov;88(5):687-90. doi: 10.1378/chest.88.5.687.
4
Airway function in stage I and stage II pulmonary sarcoidosis.
Respiration. 1984;46(1):17-25. doi: 10.1159/000194666.
5
Prognostic value of bronchoalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis.支气管肺泡灌洗淋巴细胞计数在近期诊断的结节病中的预后价值。
Chest. 1991 Aug;100(2):380-4. doi: 10.1378/chest.100.2.380.
6
Lung mechanics and their relationship to lung volumes in pulmonary sarcoidosis.
Eur Respir J. 1989 Jul;2(7):643-51.
7
Airway function in sarcoidosis: effect of short-term steroid therapy.
Respiration. 1981;42(2):98-104. doi: 10.1159/000194411.
8
Airflow limitation in sarcoidosis--a study of pulmonary function in 107 patients with newly diagnosed disease.
Respir Med. 1991 Jan;85(1):59-64. doi: 10.1016/s0954-6111(06)80211-8.
9
[Bronchoalveolar lavage (BAL) in pulmonary sarcoidosis. II. Changes in BAL cellular morphology and respiratory function in patients with sarcoidosis treated with prednisone].
Pneumonol Alergol Pol. 1993;61(3-4):159-65.
10
The sequence of physiologic changes in pulmonary sarcoidosis: correlation with radiographic stages and response to therapy.
Mt Sinai J Med. 1977 Nov-Dec;44(6):852-65.